Understanding Malaria & Typhoid Fever

ExcellenceFoundation 455 views 26 slides Aug 14, 2023
Slide 1
Slide 1 of 26
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26

About This Presentation

This presentation is from a health awareness masterclass by Dr. Leju Benjamin Modi on 12th August 2023 via Zoom and YouTube Live stream as organised by Excellence Foundation for South Sudan.

The science of wellbeing, focusing on three critical infectious diseases: Typhoid Fever, Malaria, and Viral ...


Slide Content

Malaria & typhoid
© DR LEJU BENJAMIN MODI (MBChB)
FOR EFSS AUDIENCE (ON ZOOM/YOUTUBE)
AUGUST 12 –13, 2023

Disclaimer
The material shared in this presentation is strictly for
health awareness and information purposes to the
audience, and must not be used for making self
diagnosis and/or prescriptions!
This presentation does not contribute to any CPD points.

Outline
Malaria
What it is/cause.
Transmission/signs and symptoms/diagnosis
Complications/Treatment/Prevention
Typhoid
What it is/cause.
Transmission/signs and symptoms/diagnosis
Complications/Treatment/Prevention

MALARIA
Derived from Italian words “mal” = bad, “aria” = air ➔malaria
Caused by the parasite Plasmodium;of four main species
➢P. falciparum (the most dangerous and common)
➢P. vivax
➢P. malariae
➢P. ovale
➢(P. knowlesi; Southeast Asia, common in monkeys)
Spread by the vector, female Anopheles mosquito
Possible transmission through blood transfusion, organ transplant(liver), and
placentally
Life cycle in blood (and organs like liver) and in the mosquito’s salivary glands

Incubation Period
Parasite Species Incubation Period (days)characteristic
P. falciparum9 –14 Fulminant; fever recurs
36 –48hrly
P. vivax and
ovale
12 –18 Fever spikes every
48hrs; latency in liver
P. Malariae 18 –40 Fever recurs 72hrly

Epidemiology of Malaria
WORLD MALARIA REPORT, 2022
(WHO)
•247M cases, 619,000 deaths
world wide in 2021
•234M (95%) cases in Africa, with
593000 (96%) deaths; ~ 80% in <
5years old
•South Sudan accounted for 1.2%
of cases (2,964,000) and 1.2%
deaths (7,428)
•20 people die of malaria daily in
South Sudan

Signs and Symptoms
Signs and symptoms occur in
repetitive cycles (paroxysmal)
Broadly grouped into three
stages:
Cold stage –chills and
shivering
Hot stage –warm/high fever,
headache,
Sweating stage –weakness
Fever 96%
Chills 96%
Headache 79%
Muscle Pain 60%
Palpable liver 33%
Palpable Spleen 28%
Nausea or vomiting 23%
Abdominal pain/diarrhea6%

Diagnosis
History of illness, including travel to areas of endemicity
Physical examinations –fever, etc.
Laboratory tests:
Blood microscopy (gold standard; thin/thick films); 2+ is severe
Rapid test kits; less effective if low parasites in blood
Others(Complete Blood Count (CBC), clotting, sugar levels, LP,
etc.)
PCR (at reference labs)

Complications
Low red blood cells (anemia)
Cerebral malaria (decreased consciousness; convulsions)
Organ enlargement (spleen, liver)
Kidney failure
Acute respiratory distress syndrome
Fluid accumulation (lung, brain)
Shock
jaundice
Miscarriage/preterm birth (in pregnancy; P. falciparum!)

Treatment
Pain/fever relief (paracetamol); tepid sponging
Artemisinin combination therapy (ACTs) –coartem, lumartem,
etc. (artemether/lumefantrine)
Quinine (preferable in pregnancy)
Fansidar(sulfadoxine-pyrimethamine)
Chloroquine; hydroxychloroquine
Atovaquone-proguanil
Other symptomatic treatment (transfusion, etc.)
If severe, injections then oral regimen

Prevention –3 prong
Attack Parasite
in Human Body:
Diagnose and
treat promptly
as above
Reduce contact between
humans and mosquitos/parasites:
Repellants (lotion, mosqcoil)
Mosquito net (ITN)
Use preventive anti-malarials–
doxycycline, mefloquine,
primaquine, etc.
Close doors/windows; wear
long-sleeves/socks dusk to
dawn
Mosquirixmalaria vaccine
(WHO recommended 2021 for
high burden Africa countries)
Decrease mosquito
population:
Bury stagnant
water.
Insecticides
(Doom)

Comments/Questions?
Health break

Typhoid (Enteric) Fever
Mainly caused by the bacterium, Salmonella typhi. Other species,
S. paratyphiA, B, & C are relatively infrequent
Humans the only host –may be a case(infectious as long as
bacterium appears in stools/urine) or a carrier(who may be
temporary or incubatory, excreting bacteria for 6 –8 weeks; or
chronic carrier, excreting for over a year)
Main/primary source of infection = feces(and urine) of cases;
secondary source = contaminated water, food, fingers, flies
Incubation period = 10 –14 days, but may be as short as 3 days or
as long as 21 days, depending on dose of bacteria

Mode of transmission
•Faeco-oral or uro-oral
•Worsened by human
activities:
•Open area
defecation/urination
•Contamination of
drinking water
supplies/food
•Vegetables/crops
grown in sewage water
•Low personal hygiene
Faecesand
urine from
cases or
carriers
Water
Soil
Flies
Fingers
Foods raw
or half-
cooked
Mouth of
well persons

Signs and symptoms
First week:
Characteristic “step-
ladder”, fever over 4
–5 days; mostly
afternoon hrs
Headache, vague
abdominal pain;
constipation
Weakness; muscle
pains; relative
decrease in heart
rate
Second week:
Mild organ
(liver, spleen)
enlargement –
in majority
patients
Skin rash (rose
spots) may
appear;
diarrhea
Third week:
Patient appears in
the “typhoid
stage” –prolonged
apathy, toxemia,
disorientation/com
a, apparent
diarrhea
If untreated, 5 –
10% risk of intestinal
perforation and
bleeding

Diagnosis
Widaltest –tests for antibodies to antigens of the bacterium
Unreliable as some of the antibodies not specific to S. typhi (cross-
reactivity); other antibodies rise late in the illness; false positive/false
negative results
Cultures –gold standard, different as illnesses progresses
1
st
week –bloodculture –useful since high bacterial load in blood
early in infection
3
rd
week –stoolculture
4
th
week –urineculture

Complications
General –toxemia, shock
Digestive system –intestinal bleeding/perforation (3
rd
or 4
th
week)
Nervous system –deranged, coma, meningitis
Miscellaneous –organ injury –heart, liver, kidneys, lungs,
bone infection (if sickle cell)

Treatment
Antibiotics –oral fluoroquinolones (e.g., ciprofloxacin);
chloramphenicol; amoxicillin; ampicillin;
If resistanceto fluoroquinolones –azithromycin; 3
rd
generation cephalosporins (e.g., ceftriaxone)
Chronic carrier state –prolonged (4 weeks) fluoroquinolone;
gall bladder removal in some patients
Supportive treatment –pain/fever medications, adequate
hydration, appropriate nutrition

Prevention of Enteric Fever
Control of sanitation
•Protection and
purification of drinking
water supplies
•Promotion of food
hygiene (wash fruits!)
•Improvement of basic
sanitation

Immunization/Vaccination
of
•Those living in endemic
areas
•At risk, e.g., school children,
hospital staff
•Household members
•Food handlers (restaurants)
Two types of vaccines
•The injectable typhoid
vaccine (TYPHIM –Vi)
•The live oral vaccine
(TYPHORAL)

Vaccination
Injectable TyphimVi TYPHORAL
•Single dose injectable vaccine;
•Subcutaneous or intramuscular
•For children 2years and over
•One capsule taken by mouth with
water/milk on 1
st
, 3
rd
, and 5
th
, days;
no antibiotic to be taken at this
time (live attenuated vaccine)
•For 6 years old and over
•Booster dose after 3 years

Summary
Malaria (caused by a parasite, Plasmodium), is not always associated
with typhoid (caused by a bacterium, Salmonella typhi); double
diagnosis often incorrect
A true typhoid infection has a characteristic presentation a clinician
should be able to discern and make the correct diagnosis
Best test for typhoid is culture; Widaltest is unreliable
First line treatment for typhoid is oral fluoroquinolones; use of
ceftriaxone should be minimized to prevent antibiotic resistance
Personal and environmental hygiene can prevent typhoid, practice it!
Vaccination facilities and cost in Juba? Let’s all find out!

Thank you for listening
Questions/Comments?